Hidden Multibagger Stocks by Devendra (RA: INH000026488)
前往频道在 Telegram
Disclaimer: I am a SEBI Registered Research Analyst (RA: INH000026488). All stocks, market updates, and investment-related information shared in this channel are strictly for educational and informational purposes only.
显示更多📈 Telegram 频道 Hidden Multibagger Stocks by Devendra (RA: INH000026488) 的分析概览
频道 Hidden Multibagger Stocks by Devendra (RA: INH000026488) (@hiddenmultibaggerstocks_devendra) 英语 语言赛道中的 是活跃参与者。目前社区聚集了 10 054 名订阅者，在 经济与金融 类别中位列第 11 310，并在 印度 地区排名第 37 191 位。
📊 受众指标与增长动态
自 невідомо 创建以来，项目保持高速增长，吸引了 10 054 名订阅者。
根据 07 十一月, 2026 的最新数据，频道保持稳定运转。过去 30 天订阅人数变化为 10，过去 24 小时变化为 2，整体触达仍然可观。
- 认证状态： 未认证
- 互动率 (ER)： 平均受众互动率为 26.60%。内容发布后 24 小时内通常能获得 20.23% 的反应，占订阅者总量。
- 帖子覆盖： 每篇帖子平均可获得 2 675 次浏览，首日通常累积 2 034 次浏览。
- 互动与反馈： 受众积极参与，单帖平均反应数为 13。
- 主题关注点： 内容集中在 multibagger, bull, wealth, investor, rally 等核心主题上。
📝 描述与内容策略
作者将该频道定位为表达主观观点的平台：
“Disclaimer:
I am a SEBI Registered Research Analyst (RA: INH000026488).
All stocks, market updates, and investment-related information shared in this channel are strictly for educational and informational purposes only.”
凭借高频更新（最新数据采集于 08 十一月, 2026），频道始终保持新鲜度与高覆盖。分析显示受众积极互动，使其成为 经济与金融 类别中的关键影响点。
10 054
订阅者
+224 小时
+107 天
+1030 天
帖子存档
As highlighted in my latest YouTube video and repeatedly shared on our Telegram channel, the next sector that could lead this bull run is the Pharma sector.
Many pharma stocks have already started outperforming the broader market, indicating strong buying interest.
Some of the leading outperformers include:
• Jagsonpal Pharmaceuticals
• Morepen Labs
• Shilpa Medicare
• Gland Pharma
• Supriya Lifescience
• Gufic Biosciences
• Orchid Pharma
• Kwality Pharmaceuticals
• Bliss GVS Pharma
• Beta Drugs
• Senores Pharmaceuticals
• Fredun Pharmaceuticals
"Sterlite Technologies" , a data center theme stock, is currently undergoing a healthy consolidation after its recent sharp rally. This is a normal price action seen in every strong stock after a significant move in a short period.
However, many social media experts often misinterpret such consolidation as a major crash or underperformance and advise investors to exit. In reality, during a bull market, leading stocks from outperforming sectors can continue their uptrend for a long time after periodic consolidations.
That is why only investors who truly understand the difference between bull and bear markets have the conviction to hold potential multibagger stocks through temporary consolidations instead of exiting in panic.💥💥
As I have been saying, the market is likely to remain sideways until Q1 results are announced.
Right now, the market is waiting to see which sectors and companies will deliver outstanding results. Many industries were affected over the last 2–3 months due to concerns surrounding the Strait of Hormuz and elevated crude oil prices. The impact of these factors is expected to be reflected in Q1 earnings.
TCS will announce its Q1 results on 9th July, along with management commentary. These results will be crucial in determining the near-term outlook for the IT sector and will provide insights into the impact of AI on IT companies.
This is why the stock market does not move based on daily news headlines, as many people believe. Even though the Strait of Hormuz is open, the war concerns have eased, and crude oil prices have declined, the market is still moving sideways.
To succeed in the stock market, you need to think differently and understand how the market actually works. If you simply follow social media news and popular predictions, it becomes very difficult to generate exceptional returns because the market often moves against the consensus.💥💥
"INOX INDIA " New Multibagger stock strong recovery after recent fall..🚀🚀
"HFCL " Multibagger stock continue to outperform.🚀🚀
From 117 to 218 @ 86% Gain..
Yash Highvoltage – Multibagger stock continue to outperform...🚀🚀
Why has Acutaas Chemicals delivered multibagger returns?
The answer lies in its consistently improving operating performance.
The company's operating profit margin has increased quarter after quarter: • 25% → 31% → 38% → 42%
When a company's operating margin keeps expanding over a short period, it reflects strong business execution and improving profitability. The market often rewards such companies with higher valuations.
We identified this opportunity when the stock was around ₹800 after the management provided strong growth guidance for its CDMO business. The company also entered high-growth segments such as battery chemicals and semiconductor chemicals, further strengthening its long-term growth story.
Acutaas Chemicals has become one of the first pharma-related companies to deliver massive returns in FY2025–26.
We believe the broader pharma sector rally has now begun, and this positive trend could continue.
Many investors ask how we are able to hold multibagger stocks for such a long time. The answer is simple—we first understand the business, not just the stock price. Every quarter, we closely analyse the company's results and management commentary before deciding whether to continue holding or exit.
If you don't understand the underlying business growth, you are likely to sell a winning stock after small price fluctuations and miss the real wealth creation.
This is also why we do not give fixed price targets or stop-loss levels. No one can predict how long a stock will outperform. Ultimately, a stock's long-term performance depends on the company's business growth—not just technical charts.👆
" Acutaas Chemicals " Multibagger stock Fired....🚀🚀
This stock is well-positioned to participate in the upcoming rally in the pharmaceutical sector and has the potential to outperform as the sector gains momentum...💃💃💃
🎯 One of our Premium Channel members' portfolio. "Acutaas Chemicals" has delivered an outstanding 200% return after more than one year of patient holding.
This is a reminder that you don't need dozens of multibagger stocks to create wealth. Just 4–5 high-quality multibagger investments, bought near their bottom with meaningful capital and held with patience, can generate significant long-term wealth.
We had recommended Acutaas Chemicals in free channel as well as our Diwali Muhurat Pick in 2025 at around ₹1,600.
Patience + Conviction + Buying at the right valuation = Wealth Creation.👆
"Aditya infotech " Multibagger Stock was in a consolidation phase after sharp rally. The stock now appears to be getting ready for its next move. 🚀
"Aditya infotech " Stock was in a consolidation phase after sharp rally. The stock now appears to be getting ready for its next move. 🚀
"Acutaas Chemicals" is emerging as one of the biggest wealth-creating stocks of FY 2025–26. The stock continues to show strong momentum and has the potential to generate significant returns for long-term investors.🚀🚀
From 910 to 3364 @ 270 %
As I have repeatedly said in many of my YouTube videos, the stock market does not move based on day-to-day news. In fact, it often moves against the expectations of social media experts.
In April 2026, the Smallcap Index rallied sharply, and many stocks delivered excellent returns. At that time, the Hormuz Strait was closed, the war was ongoing, crude oil was expected to cross $100, and many experts were predicting a major market crash.
Now in June , the war is over, the Hormuz Strait has reopened, and crude oil prices have fallen. Despite all this positive news, the market is not moving much, even though many experts were expecting a good rally.
This is exactly why I keep saying that the market does not follow daily news or popular opinions on social media.
One week ago, I clearly said that the next rally would begin only after the Q1 results, and that there would be very little movement in stocks before then. As you can see, that is exactly what has happened.
Our approach is completely different. We don't make predictions based on daily headlines. Instead, we analyse the market with a different method and focus on the next 1–2 months. That is why most of our market predictions have been accurate.
👉As I mentioned in my YouTube video and repeatedly over the past week, the market is likely to remain sideways with no much movement in the stocks until Q1 results begin to be announced.
Today, the pharmaceutical sector is the clear outperformer. In my latest YouTube video, I explained that the Pharma Index was on the verge of a breakout, and today's price action is supporting that view.
The following pharma stocks continue to outperform:
1. Bliss GVS
2. Beta Drugs
3. Kwality Pharmaceuticals
4. IOL Chemicals & Pharmaceuticals
5. Ind-Swift Laboratories
6. Senores Pharmaceuticals
7. Sakar Healthcare
8. KMC Speciality Hospitals
9. Venus Remedies
10. Gufic Biosciences
11. Marksans Pharma
12. Gland Pharma
